Tag: Syncona Ltd
-
Beacon Therapeutics raises $170 million in a Series B financing
•
Syncona Ltd announced that it has committed $42.5 million (£33.5 million) to a $170 million (£134 million) Series…
-
Syncona to sell Clade Therapeutics to Century Therapeutics for $45 million
•
LONDON: Syncona Ltd has signed an agreement for the sale of its portfolio company Clade Therapeutics to Century…
-
Syncona Ltd to acquire all shares of Freeline Therapeutics at the rate of $6.5/share
•
LONDON, UK: Syncona Ltd’s newly established portfolio company has entered into an agreement with Freeline Therapeutics Holdings plc…
-
Martin Murphy to step down as Chair of Syncona Investment Management Limited
•
LONDON, UK: Syncona Ltd announced that Martin Murphy is stepping down as Chair of Syncona Investment Management Limited…
-
Kemal Malik appointed non-executive director at Syncona Ltd
•
LONDON: Syncona Ltd, a leading healthcare company, announces the appointment of Dr Kemal Malik as a Non-Executive Director…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.